Two Sigma Securities’s CervoMed CRVO Stock Holding History

Two Sigma Securities’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-206	Closed	-$4K	–	2310
2022 Q1	$4K	Buy	+206	New	+$4.09K	﹤0.01%	2066
2021 Q4	–	Sell	-176	Closed	-$7K	–	1616
2021 Q3	$7K	Buy	+176	New	+$7.33K	﹤0.01%	1492
2018 Q4	–	Sell	-40	Closed	-$20K	–	2251
2018 Q3	$20K	Buy	40 +23	+135%	+$10.7K	﹤0.01%	2442
2018 Q2	$9K	Buy	17 +6	+55%	+$3.55K	﹤0.01%	2588
2018 Q1	$7K	Buy	+11	New	+$9.54K	﹤0.01%	2618

Other funds holding CRVO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Two Sigma Securities's CRVO Position: Q2 2022 in Review

Two Sigma Securities sold out of CervoMed (CRVO) in Q2 2022, closing a stake of 206 shares — an estimated $4K sold.

Two Sigma Securities first reported a position in CRVO in Q1 2018 and held it in 5 quarters. The position peaked at $20K in Q3 2018. 15 funds tracked by Wall St. Rank hold CRVO as of Q2 2022.

Two Sigma Securities reported no remaining CervoMed position as of Q2 2022 after selling out during the quarter.
Two Sigma Securities sold 206 CervoMed shares in Q2 2022, an estimated $4K.
Two Sigma Securities first reported a position in CervoMed in Q1 2018 and held it in 5 quarters.
Two Sigma Securities's CervoMed position peaked at $20K in Q3 2018.
15 funds tracked by Wall St. Rank held CervoMed as of Q2 2022.

Based on Two Sigma Securities's 13F filing for Q2 2022, filed 15 Aug 2022.